Sweden enters the mammography debate
This article was originally published in Clinica
Executive Summary
The ongoing questioning of the value of mammography screening has prompted the Swedish board of health and welfare (SOS) to make its own study of the issue. Last week SOS, together with the Cancer Fund, met with experts from a number of European countries and the US to debate the benefits and disadvantages of breast cancer screening. "In order to take a stand on the mammography question we have to have facts from many different areas, and this is what we achieved at the meeting," said Kenneth Nilsson, chairman of the Cancer Fund's research body.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.